Venus Medtech (Hangzhou) Inc.

VMTHF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$134,772-$534,226-$206,487-$353,566
Dep. & Amort.$0$52,619$58,490$68,731
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$55,800$253,791-$101,630
Other Non-Cash$134,772$367,298-$23,546$107,762
Operating Cash Flow$0-$58,509$82,248-$278,703
Investing Activities
PP&E Inv.$0$9,642-$43,558-$207,347
Net Acquisitions$0-$483$0$0
Inv. Purchases$0-$426$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$8,495$6,432$9,171
Investing Cash Flow$0$17,228-$37,126-$198,176
Financing Activities
Debt Repay.$0-$423,138-$327,747$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$273,773-$10,227-$101,275
Financing Cash Flow$0-$149,365-$337,974-$101,275
Forex Effect$0$2,839$4,299$14,315
Net Chg. in Cash$0$442,313-$144,277-$339,385
Supplemental Information
Beg. Cash$0-$144,277$0$1,373,165
End Cash$0$298,036-$144,277-$339,385
Free Cash Flow$0-$56,507$38,690-$486,050
Venus Medtech (Hangzhou) Inc. (VMTHF) Financial Statements & Key Stats | AlphaPilot